Mayasari Lim, PhD

Exemplary, clear, concise review: CAR T cell combination therapies to treat #cancer w/ the most efficient figure ever! 😉 & table of clinical trials testing different agents to enhance #CARTCell efficacy. #immunotherapy @carlhjune @UgiUslu @Cancer_Cell @msofiacastelli cell.com/cancer-cell/fu…

Candid and open conversation on #bioprinting great listen! 3DPOD Episode 196: Bioprinting and Biofabrication with Dietmar Hutmacher, Queensland University of Technology 3dprint.com/308791/3dpod-e…

Wonderful opportunity for a great position in our growing School of BME. #biomaterials #3dprinting #tissue_engineering See details below 👇 and please repost.

Have a look at this new global health foresight report on 3D bioprinting from @WHO -> iris.who.int/handle/10665/3…. Thanks for having me as a core expert on this project to discuss the future and potential of bioprinting. @CPC_usyd @ASBTE1 @ISBioFab @syd_health

@Khoonono @WHO @CPC_usyd @ASBTE1 @ISBioFab @syd_health Thanks for sharing this Khoon. Looking forward to reading this!

ARM says EU plans would take 90% of advanced therapies off the market shar.es/afVEJq

Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy whitehouse.gov/briefing-room/… via @whitehouse

@BLLPHD Great book. Thoroughly enjoyed.

I think I will start this topical book tonight ⚖️

ISCT partners to provide ‘urgent’ training programs for CGT workforce buff.ly/2YYsJ0F

CRISPR, ViaCyte beat Vertex to the clinic with diabetes cell therapy that evades the immune system - endpts.com/crispr-viacyte…

@TomasGF90 @LehighU @dannykelly1978 @fjobrien @kentleach5 Congrats.

I am thrilled to announce that I will be joining the @LehighU BioE Department as an Assistant Professor in January 2022! Thanks to everyone that has helped me in this journey specially my mentors @dannykelly1978 @fjobrien & @kentleach5 who couldn’t have been more supportive!

We are pleased to announce the launch of our Manufacturing Science and Technology (MSAT) service to help you simplify and improve your cell culture media process workflow. Request the MSAT service and start simplifying your media preparation process now. ow.ly/5BVn50GeTvT

A great #HBR IdeaCast listen on Building Successful Hybrid Teams #workplace #podcast buff.ly/3EECjWr

Talent mobility is absolutely critical in retaining and growing best talents in any top organization - here are some great tips from #HBR on how to do this buff.ly/3DAwcC3

These Are The Top Priorities & Challenges For New CDER Director Patrizia Cavazzoni, M.D. buff.ly/3DjQQGq

How industry is meeting FDA expectations on the impact of COVID-19 biophorum.com/how-industry-i… via @communications@biophorum.com

From Professor To Regenerative Medicine Company CEO What a great story - years of dedication, sacrifice and resilience, and having the right people to make this happen buff.ly/3fP5ifA

How Pharma Executives View Future Business Travel buff.ly/3lPUp0O

Why China's climate policy matters to us all buff.ly/3s6JSPR

Interesting survey and insight on how this might impact diversity in the workplace post COVID Don’t Let Employees Pick Their WFH Days buff.ly/3Aacivi